B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | Leukemia |
| Volume | 28 |
| Pages (from-to) | 2109-12 |
| Number of pages | 4 |
| ISSN | 0887-6924 |
| DOIs | |
| Publication status | Published - 12 Jun 2014 |
ID: 117551379